IMUX compared with KIDS: revenue, margins and what each company keeps, and the suppliers and customers both name

IMUXImmunic, Inc.

Mkt capRevenueRevenue

KIDSOrthopediatrics Corp

Mkt capRevenueRevenue

Compare

IMUXImmunic, Inc.

KIDSOrthopediatrics Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

IMUX1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±18.3%▲+9.79%×0.54

KIDS

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q3 FY26—▲+29.30%—

Q2 FY26±19.2%▲+6.85%×0.35

= impliedIMUX realized, solidKIDS realized, hatchedOne scale, both sides: full bar = 30%× = |realized| ÷ impliedSource: market data

Q1 FY26

±28.5%

▲+3.78%

×0.13

Feb 27 '26±21.8%▲+7.76%×0.36

IMUXImmunic, Inc.

7.40▼−6.82%· post 7.37

Mkt cap$99.9MRevenue—Revenue—

KIDSOrthopediatrics Corp

32.23▼−3.81%· post 32.23

ClosedNov 5 '26

Mkt cap$841.3MRevenue$73MQ3 FY26Revenue$236MFY25

Compare

ClosedNov 5 '26

IMUXImmunic, Inc.

KIDSOrthopediatrics Corp

7.40▼−6.82%post 7.37

Price

32.23▼−3.81%post 32.23

$99.9M

Mkt cap

$841.3M

—

Revenue

$73MQ3 FY26

—

Revenue

$236MFY25

IMUX7.40▼−6.82%vsKIDS32.23▼−3.81%ClosedNov 5 '26